Viewing Study NCT05431569


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-03-01 @ 10:08 AM
Study NCT ID: NCT05431569
Status: UNKNOWN
Last Update Posted: 2022-06-24
First Post: 2022-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 6MW3211-2022-CP203
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators